How Safe Are COVID-19 Vaccines in Individuals with Immune-Mediated Inflammatory Diseases? The SUCCEED Study

How Safe Are COVID-19 Vaccines in Individuals with Immune-Mediated Inflammatory Diseases? The SUCCEED Study

We were tasked by Canada’s COVID-19 Immunity Task Force to describe severe adverse events (SAEs) associated with emergency department (ED) visits and/or hospitalizations in individuals with immune-mediated inflammatory diseases (IMIDs). At eight Canadian centres, data were collected from adults with...

Full description

Bibliographic Details
Main Authors: Olga Tsyruk, Gilaad G. Kaplan, Paul R. Fortin, Carol A Hitchon, Vinod Chandran, Maggie J. Larché, Antonio Avina-Zubieta, Gilles Boire, Ines Colmegna, Diane Lacaille, Nadine Lalonde, Laurie Proulx, Dawn P. Richards, Natalie Boivin, Christopher DeBow, Lucy Kovalova-Wood, Deborah Paleczny, Linda Wilhelm, Luck Lukusa, Daniel Pereira, Jennifer LF. Lee, Sasha Bernatsky, on behalf of the SUCCEED Investigative Team
Format: Article
Language:English
Published: MDPI AG 2024-09-01
Series:Vaccines
Subjects:
COVID-19 vaccine safety
immune-mediated inflammatory diseases
serious adverse events
Online Access:https://www.mdpi.com/2076-393X/12/9/1027

Internet

https://www.mdpi.com/2076-393X/12/9/1027

Similar Items